<!DOCTYPE html>
<html>
  <head>
    <title>Long-term aspirin/antiplatelet therapy</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Roryâ€™s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/cardiovascular/">cardiovascular</a></li>
      <li><a href="/notes/cardiovascular/cardiovasulcar risk management/">cardiovasulcar risk management</a></li>
      <li class="active">Long-term aspirin/antiplatelet therapy</li>
  </ol>

  <div class="page-header">
 
    <h1>Long-term aspirin/antiplatelet therapy</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Long-term aspirin/antiplatelet therapy</strong></a>
          <div class="toc">
<ul>
<li><a href="#after-angina-or-mi">after angina or MI</a></li>
<li><a href="#risk-6220">risk >20%</a></li>
<li><a href="#contraindications">contraindications:</a><ul>
<li><a href="#risks">risks</a></li>
</ul>
</li>
<li><a href="#ticagrlor-brilinta">Ticagrlor (Brilinta)</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <ul>
<li>
<p>Should not be added if on oral anticoagulants</p>
</li>
<li>
<p>Generally <strong>Not</strong> recommended risk \&lt;20%</p>
</li>
<li>
<p>Can be considered for high-risk primary prevention: taking into account harms and benefits</p>
</li>
<li>
<p>Strongly recommended people with established cardiovascular disease</p>
<ul>
<li>reduces risk of cardiovascular event by about 25%</li>
</ul>
</li>
</ul>
<h3 id="after-angina-or-mi">after angina or MI</h3>
<ul>
<li>low dose aspirin</li>
</ul>
<h3 id="risk-6220">risk >20%</h3>
<ul>
<li>commence aspirin</li>
</ul>
<h3 id="contraindications">contraindications:</h3>
<ul>
<li>
<p>Aspirin allergies/intolerance</p>
</li>
<li>
<p>active peptic ulceration</p>
</li>
<li>
<p>uncontrolled BP and other major bleeding risks)</p>
</li>
</ul>
<h4 id="risks">risks</h4>
<ul>
<li>
<p>intracranial haemorrhage = 2/1000 / year</p>
</li>
<li>
<p>extracranial haemorrhage 1-2/1000</p>
<ul>
<li>most non-fatal</li>
</ul>
</li>
<li>
<p>upper GI bleed/perforation</p>
<ul>
<li>2x increase</li>
</ul>
</li>
</ul>
<h3 id="ticagrlor-brilinta">Ticagrlor (Brilinta)</h3>
<ul>
<li>
<p>reversibly inhibits platelet adenosine diphosphate p2y12 receptors</p>
<ul>
<li>
<p>rapid inhibition of platelet activation and aggregation</p>
</li>
<li>
<p>clopidogrel = prodrug</p>
<ul>
<li>
<p>CYP2c19</p>
</li>
<li>
<p>30-40% people of Maori, PI and aisan decent</p>
<ul>
<li>
<p>reduced CYP2c19</p>
</li>
<li>
<p>compared to 15% Eruopeans</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>co-administered with aspirin</p>
<ul>
<li>dual anti-platelet</li>
</ul>
</li>
<li>
<p>indicated prevention of atherothromboci events in adult patients with ACS</p>
<ul>
<li>N-STEACS/STEACS</li>
</ul>
</li>
<li>
<p>Special authority</p>
<ul>
<li>
<p>Patient has recently been diagnosed with STEACS/STEACS</p>
<ul>
<li>days/weeks compared to months</li>
</ul>
</li>
<li>
<p>Fibrinolytic therapy not been given in the last 24 hours and is not planned</p>
</li>
</ul>
</li>
<li>
<p>Evidence</p>
<ul>
<li>
<p>PLATO</p>
<ul>
<li>
<p>ticagrelor + aspirin > clopidogrel + aspirin</p>
<ul>
<li>
<p>lower risk of ischaemic events and death</p>
</li>
<li>
<p>absolute risk reduction 16%</p>
</li>
<li>
<p>RR 16%</p>
</li>
<li>
<p>NNT 54</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>load with 180mg</p>
</li>
<li>
<p>90mg bd with or without food</p>
</li>
<li>
<p>Black box warning</p>
<ul>
<li>should not be used concurrrently with doses of aspirin >100mg</li>
</ul>
</li>
<li>
<p>contraindications</p>
<ul>
<li>
<p>active bleeding</p>
</li>
<li>
<p>history of intracranial haemorrhage</p>
</li>
<li>
<p>no data on safety in those who have had fibrinolytic thearpy</p>
</li>
</ul>
</li>
<li>
<p>cautions</p>
<ul>
<li>
<p>increase risk of bleeding</p>
</li>
<li>
<p>nsaids</p>
</li>
<li>
<p>?brady cardia</p>
<ul>
<li>
<p>excluded from PLATO</p>
</li>
<li>
<p>used with caution unless PPM fitted</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Interactions</p>
<ul>
<li>
<p>CYP3A4</p>
</li>
<li>
<p>weak inhibitor</p>
</li>
</ul>
</li>
<li>
<p>Adverse effects</p>
<ul>
<li>
<p>Bleeding</p>
</li>
<li>
<p>Dyspnoea</p>
<ul>
<li>
<p>increase risk of dyspnoea compared to clopidogrel</p>
</li>
<li>
<p>?mechanism</p>
</li>
</ul>
</li>
<li>
<p>elevations in Cr and urate</p>
</li>
</ul>
</li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
